consumer genomics
Nucleus Genomics Raises $14M in Series A Financing
The firm aims to use the new funding to launch heritable disease and personalized drug metabolism genetic tests.
23andMe, Mirador Therapeutics Ink Immunology Target Validation Deal
Mirador Therapeutics will leverage a targeted set of 23andMe's genetic data for immune-related biomarker and drug discovery.
23andMe CEO Wojcicki Not Open to Third-Party Takeover Proposals
In a regulatory filing, 23andMe CEO Anne Wojcicki issued a brief statement reiterating that she sees taking the company private as the "best path."
23andMe Receives Warning of Nasdaq Listing Noncompliance
The resignation of the company's independent directors triggered the warning, which grants the company until Oct. 3 to submit a plan to regain compliance.
23andMe Independent Board Directors Resign, Citing Lack of Progress on Take-Private Proposal
The directors wrote that disagreements on strategic direction and Wojcicki's sizable voting power meant that their resignation best served shareholder interests.